The benefits of mass spectrometry for expediting biologics to patients
European Pharmaceutical Review
SEPTEMBER 20, 2023
A manufacturer that can demonstrate an in-depth understanding of its product and process will have the best chance of minimising risks during product development. While the approval of any product is based on the totality of data in the filing, a strong demonstration of overall product knowledge can expedite regulatory review.
79 
Let's personalize your content